R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Merit Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Merit Medical Systems's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Merit Medical Systems's R&D?
- Merit Medical Systems (MMSI) reported R&D of $22.61M in Q1 2026.
- How has Merit Medical Systems's R&D changed year-over-year?
- Merit Medical Systems's R&D increased by 0.6% year-over-year, from $22.48M to $22.61M.
- What is the long-term trend for Merit Medical Systems's R&D?
- Over 4 years (2021 to 2025), Merit Medical Systems's R&D has grown at a 8.1% compound annual growth rate (CAGR), from $71.25M to $97.35M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.